Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 29,271 |
|
|||||
| News | - | ||||||
| Day High | 3.935 | Low High |
|||||
| Day Low | 3.76 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.195 | 5.21% | 3.935 | 13:44:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.76 | 3.76 | 3.935 | 3.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 330 | 29,271 | $ 3.87 | $ 113,347 | - | 2.33 - 8.695 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:44:48 | 39 | $ 3.95 | USD |
Verrica Parmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 165.31M | 42.06M | - | 9.03M | -24.49M | -0.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Verrica Parmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRCA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.74 | 3.94 | 3.37 | 3.70 | 80,317 | 0.195 | 5.21% |
| 1 Month | 3.71 | 4.11 | 2.86 | 3.41 | 153,680 | 0.225 | 6.06% |
| 3 Months | 4.37 | 4.48 | 2.86 | 3.76 | 172,375 | -0.435 | -9.95% |
| 6 Months | 5.76 | 7.755 | 2.86 | 5.14 | 295,679 | -1.83 | -31.68% |
| 1 Year | 2.60 | 8.695 | 2.33 | 5.42 | 228,658 | 1.34 | 51.35% |
| 3 Years | 9.26 | 18.42 | 1.77 | 6.02 | 177,328 | -5.33 | -57.51% |
| 5 Years | 11.65 | 18.67 | 1.77 | 7.09 | 139,042 | -7.72 | -66.22% |
Verrica Parmaceuticals Description
| Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. |
